136 related articles for article (PubMed ID: 22703300)
21. Family of peptides synthesized in the human body have anticancer effects.
Vesely DL
Anticancer Res; 2014 Apr; 34(4):1459-66. PubMed ID: 24692673
[TBL] [Abstract][Full Text] [Related]
22. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
[TBL] [Abstract][Full Text] [Related]
23. Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2006; 26(5A):3217-22. PubMed ID: 17094432
[TBL] [Abstract][Full Text] [Related]
24. Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator.
Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
In Vivo; 2010; 24(2):125-9. PubMed ID: 20363982
[TBL] [Abstract][Full Text] [Related]
25. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
[TBL] [Abstract][Full Text] [Related]
26. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
[TBL] [Abstract][Full Text] [Related]
27. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
28. Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
Eichelbaum EJ; Sun Y; Alli AA; Gower WR; Vesely DL
Eur J Clin Invest; 2008 Aug; 38(8):562-70. PubMed ID: 18717826
[TBL] [Abstract][Full Text] [Related]
29. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.
Vesely DL; Perez-Lamboy GI; Schocken DD
J Card Fail; 2001 Mar; 7(1):55-63. PubMed ID: 11264551
[TBL] [Abstract][Full Text] [Related]
30. Intact negative feedback of four cardiac hormones in congestive heart failure.
Vesely DL; San Miguel GI; Hassan I; Schocken DD
Metabolism; 2002 May; 51(5):582-8. PubMed ID: 11979389
[TBL] [Abstract][Full Text] [Related]
31. Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Cancer Lett; 2007 Aug; 254(1):94-101. PubMed ID: 17399891
[TBL] [Abstract][Full Text] [Related]
32. New anticancer agents: hormones made within the heart.
Vesely DL
Anticancer Res; 2012 Jul; 32(7):2515-21. PubMed ID: 22753708
[TBL] [Abstract][Full Text] [Related]
33. Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
Mao G; Zheng S; Li J; Liu X; Zhou Q; Cao J; Zhang Q; Zheng L; Wang L; Qi C
Anticancer Agents Med Chem; 2022; 22(9):1735-1741. PubMed ID: 34515012
[TBL] [Abstract][Full Text] [Related]
34. Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer.
Vesely DL
Anticancer Res; 2016 Nov; 36(11):5693-5700. PubMed ID: 27793890
[TBL] [Abstract][Full Text] [Related]
35. Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.
Eichelbaum EJ; Vesely BA; Alli AA; Sun Y; Gower WR; Vesely DL
Endocrine; 2006 Dec; 30(3):325-32. PubMed ID: 17526945
[TBL] [Abstract][Full Text] [Related]
36. Four peptides decrease the number of human pancreatic adenocarcinoma cells.
Vesely BA; McAfee Q; Gower WR; Vesely DL
Eur J Clin Invest; 2003 Nov; 33(11):998-1005. PubMed ID: 14636304
[TBL] [Abstract][Full Text] [Related]
37. Metabolic targets of cardiac hormones' therapeutic anti-cancer effects.
Vesely DL
Curr Pharm Des; 2010; 16(9):1159-66. PubMed ID: 20030620
[TBL] [Abstract][Full Text] [Related]
38. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA
Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450
[TBL] [Abstract][Full Text] [Related]
39. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K
Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048
[TBL] [Abstract][Full Text] [Related]
40. Atrial natriuretic hormone, vessel dilator, long acting natriuretic hormone, and kaliuretic hormone decrease circulating prolactin concentrations.
Vesely DL; San Miguel GI; Hassan I; Schocken DD
Horm Metab Res; 2002 May; 34(5):245-9. PubMed ID: 12063637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
